免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Relivion

K 號:K212106 · 2021-08-02

決定日期2021-08-02
產品代碼PCC
諮詢委員會NE (請提供完整的英文描述,以便進行翻譯。)
決定相當於

器材摘要

Relivion is the device name listed in this FDA 510(k) record. The listed applicant is Neurolief , Ltd.. It received FDA 510(k) clearance on 2021-08-02 under 510(k) number K212106. The device is classified under product code PCC. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Relivion?

Relivion is a medical device that received FDA 510(k) clearance on 2021-08-02. The listed applicant is Neurolief , Ltd.. The 510(k) number is K212106.

When did Relivion receive FDA 510(k) clearance?

Relivion received FDA 510(k) clearance on 2021-08-02, under 510(k) number K212106.

Who is the listed applicant for Relivion?

The FDA 510(k) record lists Neurolief , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Relivion?

The FDA product code for Relivion is PCC.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Neurolief , Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:PCC)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑